|
SYNJ2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05759999999389E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.035300E-04 |
| Normal-vs-Stage2 |
2.36309999999129E-05 |
| Normal-vs-Stage3 |
4.796000E-01 |
| Normal-vs-Stage4 |
4.476200E-02 |
| Stage1-vs-Stage2 |
3.170600E-01 |
| Stage1-vs-Stage3 |
4.246200E-01 |
| Stage1-vs-Stage4 |
8.000800E-01 |
| Stage2-vs-Stage3 |
2.247400E-01 |
| Stage2-vs-Stage4 |
2.700400E-01 |
| Stage3-vs-Stage4 |
6.453600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.32959999996374E-06 |
| Normal-vs-AfricanAmerican |
4.677500E-02 |
| Normal-vs-Asian |
8.164800E-03 |
| Caucasian-vs-AfricanAmerican |
3.784400E-01 |
| Caucasian-vs-Asian |
8.275800E-01 |
| AfricanAmerican-vs-Asian |
3.744800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.60110003033509E-09 |
| Normal-vs-Female |
8.448400E-01 |
| Male-vs-Female |
2.438600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.015600E-01 |
| Normal-vs-Extreme_Weight |
3.57210000001551E-06 |
| Normal-vs-Obese |
1.358730E-03 |
| Normal-vs-Extreme_Obese |
2.48970000005233E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.646590E-01 |
| Normal_Weight-vs-Obese |
4.776800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.095500E-02 |
| Extreme_Weight-vs-Obese |
1.648830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.100240E-01 |
| Obese-vs-Extreme_Obese |
4.436400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.325000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.390000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.17450000228325E-08 |
| Normal-vs-Age(81-100Yrs) |
6.63030000014331E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.062400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.729900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.823600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.055000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.361620E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.057200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.09719999996649E-06 |
| Normal-VS-Type2 PRCC |
1.940520E-03 |
| Normal-VS-KIRP CIMP |
2.920600E-01 |
| Normal-VS-Unclassified PRCC |
2.123900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.265000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.940400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.071200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.766100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.099000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.597600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.5102032391876E-11 |
| Normal-vs-N1 |
7.324200E-01 |
| Normal-vs-N2 |
1.752850E-01 |
| N0-vs-N1 |
2.135900E-02 |
| N0-vs-N2 |
7.827700E-02 |
| N1-vs-N2 |
5.763800E-01 |
|
|
